Get started
Author

Kurt A. Schalper

ORCID: 0000-0001-5692-4833
Observed ORCID: 0000-0001-5692-4833
OpenAlex ID: A5136688988
Distinct genomic and immunologic tumor evolution in germline TP53-driven breast cancers
2026 · Nabamita Boruah, David Hoyos, et al. · Nature Communications · 4
Machine Learning Assessment of Pathologic Response in Lung Cancer Resections After Neoadjuvant Therapy—IASLC MPR Project
2026 · Sanja Dacic, Daniel Shenker, et al. · Journal of Thoracic Oncology · 2
Clinical Significance of Tumor Infiltrating Lymphocytes and Modulation by Neoadjuvant Chemotherapy in Colorectal Cancer Liver Metastases
2026 · Yasaman Rezaie, Kerryan Ashley, et al. · Cancers
AI-derived CD8⁺ cytotoxic T-cell immune signatures from baseline H&E images to predict immunotherapy benefit over chemotherapy in non–small cell lung cancer: Blinded validation in CheckMate-227 (CM227).
2026 · Cristian Barrera, Wiem Safta, et al. · Journal of Clinical Oncology
Pretreatment spatial immune architecture and 1-year clinical benefit to first-line ICB in advanced melanoma.
2026 · Karim Amrane, Patrice Hemon, et al. · Journal of Clinical Oncology
NSCLC brain metastases exhibit reduced HLA-I antigen presentation machinery and immune evasion independent of IFNγ signaling defects
2026 · Noelia Vilariño, Miguel Lopez de Rodas, et al. · Molecular Cancer
Additional file 1 of NSCLC brain metastases exhibit reduced HLA-I antigen presentation machinery and immune evasion independent of IFNγ signaling defects
2026 · Noelia Vilariño, Miguel Lopez de Rodas, et al. · Figshare
Additional file 2 of NSCLC brain metastases exhibit reduced HLA-I antigen presentation machinery and immune evasion independent of IFNγ signaling defects
2026 · Noelia Vilariño, Miguel Lopez de Rodas, et al. · Figshare
Tumor cell-intrinsic programs of metabolic adaptation and immune evasion in colorectal cancer liver metastases (CRCLMs).
2026 · Xuanyi Li, Kerryan Ashley, et al. · Journal of Clinical Oncology
Works count: 9
Citation count: 6
H-index: 2
I10-index:
Year
Topic
Type